YD Bio Ltd. -30YDESWPreferred / convertible
13F holders, Q2 2026 (June 30)8holders −1
0new positions
1sold out
$0.34avg. 13F price*
At the end of Q2 2026, 8 institutions reported holding YD Bio Ltd. -30 (YDESW) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 1 sold out. The largest holders were Cypress Capital Management LLC (WY) ($1.4M), Oasis Management Co Ltd. ($225K) and Cerity Partners LLC ($99K).
- Company
- YD Bio Ltd. -30
- CUSIP
- G9835J103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $1 |
All 13F filers, Q1 2026 → Q2 2026: 54,602 shares bought and 20,762 shares sold, net +33,840 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Cypress Capital Management LLC (WY) | — | Add +1.2% | 4,644,452 | $1.4M |
| Oasis Management Co Ltd. | — | No change | 100,000 | $225K |
| Cerity Partners LLC | — | No change | 320,089 | $99K |
| True North Advisors, LLC | — | No change | 220,819 | $68K |
| Clear Street Group Inc. | — | No change | 102,358 | $32K |
| Aristeia Capital, L.L.C. | — | No change | 63,274 | $17K |
| Merit Financial Group, LLC | — | Reduce -51.9% | 19,239 | $6K |
| Concurrent Investment Advisors, LLC | — | No change | 17,672 | $5K |
"% of holder's portfolio" is YDESW's weight in each manager's 13F, not the share of YD Bio Ltd. -30 the manager owns.